Pure Global

BXOS110 Injection in the Treatment of Acute Ischaemic Stroke - Trial NCT06322394

Access comprehensive clinical trial information for NCT06322394 through Pure Global AI's free database. This Phase 2 trial is sponsored by Biocells (Beijing) Biotech Co.,Ltd and is currently Recruiting. The study focuses on Acute Ischemic Stroke. Target enrollment is 300 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06322394
Phase 2
Recruiting
drug
Trial Details
ClinicalTrials.gov • NCT06322394
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
BXOS110 Injection in the Treatment of Acute Ischaemic Stroke
A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase II Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset

Study Focus

Acute Ischemic Stroke

high-dose BXOS110

Interventional

drug

Sponsor & Location

Biocells (Beijing) Biotech Co.,Ltd

Shaoguan,Hengshui,Shijiazhuang,Daqing,Anyang,Nanyang,Nanyang,Nanyang,Meihekou,Chaoyang,Fuxin,Shenyang,Shenyang,Shenyang,Tieling,Chifeng,Xianyang,Liaocheng,Linyi,Tengzhou,Datong,Linfen,Linfen,Beijing, China

Timeline & Enrollment

Phase 2

Feb 07, 2024

Sep 01, 2025

300 participants

Primary Outcome

Proportion of subjects with mRS score 0-2 on day 90

Summary

The purpose of this study was to evaluate the effectiveness of early administration of
 BXOS110 for injection in reducing overall disability in patients with acute ischaemic stroke.

ICD-10 Classifications

Stroke, not specified as haemorrhage or infarction
Sequelae of stroke, not specified as haemorrhage or infarction
Cerebral infarction
Cerebral infarction, unspecified
Transient cerebral ischaemic attack, unspecified

Data Source

ClinicalTrials.gov

NCT06322394

Non-Device Trial